Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
IPO Year:
Exchange: NASDAQ
Website: semlerscientific.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
11/2/2022 | $60.00 → $45.00 | Buy → Neutral | B. Riley Securities |
3/7/2022 | $145.00 → $70.00 | Buy | B. Riley Securities |
11/2/2021 | $175.00 → $145.00 | Buy | B. Riley Securities |
10/26/2021 | $151.00 → $175.00 | Buy | B. Riley Securities |
4 - Semler Scientific, Inc. (0001554859) (Issuer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
S-8 - Semler Scientific, Inc. (0001554859) (Filer)
10-Q - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
DEF 14A - Semler Scientific, Inc. (0001554859) (Filer)
EFFECT - Semler Scientific, Inc. (0001554859) (Filer)
S-3/A - Semler Scientific, Inc. (0001554859) (Filer)
10-Q - Semler Scientific, Inc. (0001554859) (Filer)
B. Riley Securities downgraded Semler Scientific from Buy to Neutral and set a new price target of $45.00 from $60.00 previously
B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $70.00 from $145.00 previously
B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $145.00 from $175.00 previously
B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $175.00 from $151.00 previously
SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin activity and holdings, capital markets activity, and BTC yield, a key performance indicator that it recently adopted. BTC Update Semler Scientific announced that, during the period between November 6, 2024 and November 15, 2024, it acquired 215 bitcoins for $17.7 million in cash, at an average price of $82,502 per bitcoin,
SANTA CLARA, Calif., Nov. 4, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the third quarter ended September 30, 2024. In addition, Semler Scientific announced the purchase of an additional 47 bitcoins for an aggregate amount of $3.0 million from operating cash flow since August 26, 2024. Semler Scientific now holds 1,058 bitcoins for a total purchase amount of $71.0 million as of November 4, 2024. "We are
SANTA CLARA, Calif., Oct. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the third quarter and nine months ended September 30, 2024, as well as provide an update on its Bitcoin holdings after the close of U.S. financial markets on Monday, November 4, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Eric Semler, chairman, Renae Cormier, chief financial officer, and Jennifer Oliva-Herrington, chief operating offi
SANTA CLARA, Calif., Aug. 26, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it has purchased an additional 83 bitcoins for $5.0 million in cash, inclusive of fees and expenses. As of August 26, 2024, Semler Scientific holds a total of 1,012 bitcoins, which were acquired for $68.0 million, inclusive of fees and expenses. "We recently purchased additional bitcoins using primarily cash from operations as well as capital rais
SANTA CLARA, Calif., Aug. 5, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the second quarter ended June 30, 2024. In addition, the Company announced the purchase of an additional 101 bitcoins for an aggregate amount of $6.0 million. Since announcing the adoption of a bitcoin treasury strategy on May 28, 2024, the Company has purchased 929 bitcoins for a total of $63.0 million. "We are pleased to report st
SANTA CLARA, Calif., July 22, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the second quarter and six months ended June 30, 2024, after the close of U.S. financial markets on Monday, August 5, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Eric Semler, chairman, Renae Cormier, chief financial officer, and Jennifer Oliva-Herrington, chief operating officer, will join him on the call. Please submit questions prio
SANTA CLARA, Calif., June 6, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it has purchased an additional 247 bitcoins for an aggregate $17 million in cash, inclusive of fees and expenses. As of June 6, 2024, Semler holds a total of 828 bitcoins, which were acquired for an aggregate $57 million, inclusive of fees and expenses. "Semler remains focused on our two strategies of expanding our healthcare business and acquiri
SANTA CLARA, Calif., May 28, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, announced today that its board of directors has adopted bitcoin as its primary treasury reserve asset. In addition, Semler Scientific announced that it has purchased 581 bitcoins for an aggregate amount of $40 million, inclusive of fees and expenses. "Our bitcoin treasury strategy and purchase of bitcoin underscore our belief that bitcoin is a reliable store of value a
2024 Q1 highlights compared to the corresponding period of 2023: First quarter revenues were $15.9 million, a decrease of 13%First quarter net income was $6.1 million, an increase of 22%Cash, cash equivalents and restricted cash balance increased to $62.9 millionSANTA CLARA, Calif., May 7, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today reported financial results for the first quarter ended March 31, 2024. "We had
SANTA CLARA, Calif., April 23, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of U.S. financial markets on Tuesday, May 7, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, chief financial officer, and Jennifer Oliva-Herrington, chief operating officer, will join him on the call.
SANTA CLARA, Calif., July 11, 2023 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced the appointment of a chief financial officer (CFO), record quarterly revenues expected for the second quarter of 2023 and a strategic streamlining. "We are pleased to announce Ms. Renae Cormier will lead our accounting, finance, investor relations and business strategy efforts as chief financial officer," said Doug Murphy-Chuto
Eric Semler Appointed as Chairman SANTA CLARA, Calif., April 19, 2023 /PRNewswire/ -- - Semler Scientific, Inc. (NASDAQ:SMLR) today announced that Eric Semler and William H.C. Chang (together, the "Investors"), who collectively beneficially own more than 20% of Semler Scientific's outstanding shares, will immediately join Semler Scientific's board of directors as new independent directors. Mr. Semler will join the board as a Class II director standing for reelection at the 2023 annual meeting of stockholders and will be appointed as Chairman of the board, and Mr. Chang will join the board as a Class I director standing for reelection at the 2025 annual meeting of stockholders. The board will
SANTA CLARA, Calif., March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, announces that Doug Murphy-Chutorian, M.D. has informed the board of directors of his intention to step down from his position as chief executive officer (CEO) of Semler Scientific and assist for a transition period. He will continue to serve as a member of the board of directors at least through the remainder of his 2024 term. "I am proud of the business that we hav
SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin activity and holdings, capital markets activity, and BTC yield, a key performance indicator that it recently adopted. BTC Update Semler Scientific announced that, during the period between November 6, 2024 and November 15, 2024, it acquired 215 bitcoins for $17.7 million in cash, at an average price of $82,502 per bitcoin,
SANTA CLARA, Calif., Nov. 4, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the third quarter ended September 30, 2024. In addition, Semler Scientific announced the purchase of an additional 47 bitcoins for an aggregate amount of $3.0 million from operating cash flow since August 26, 2024. Semler Scientific now holds 1,058 bitcoins for a total purchase amount of $71.0 million as of November 4, 2024. "We are
SANTA CLARA, Calif., Oct. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the third quarter and nine months ended September 30, 2024, as well as provide an update on its Bitcoin holdings after the close of U.S. financial markets on Monday, November 4, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Eric Semler, chairman, Renae Cormier, chief financial officer, and Jennifer Oliva-Herrington, chief operating offi
SANTA CLARA, Calif., Aug. 5, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the second quarter ended June 30, 2024. In addition, the Company announced the purchase of an additional 101 bitcoins for an aggregate amount of $6.0 million. Since announcing the adoption of a bitcoin treasury strategy on May 28, 2024, the Company has purchased 929 bitcoins for a total of $63.0 million. "We are pleased to report st
SANTA CLARA, Calif., July 22, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the second quarter and six months ended June 30, 2024, after the close of U.S. financial markets on Monday, August 5, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Eric Semler, chairman, Renae Cormier, chief financial officer, and Jennifer Oliva-Herrington, chief operating officer, will join him on the call. Please submit questions prio
2024 Q1 highlights compared to the corresponding period of 2023: First quarter revenues were $15.9 million, a decrease of 13%First quarter net income was $6.1 million, an increase of 22%Cash, cash equivalents and restricted cash balance increased to $62.9 millionSANTA CLARA, Calif., May 7, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today reported financial results for the first quarter ended March 31, 2024. "We had
SANTA CLARA, Calif., April 23, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of U.S. financial markets on Tuesday, May 7, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, chief financial officer, and Jennifer Oliva-Herrington, chief operating officer, will join him on the call.
2023 Q4 and full year highlights compared to the corresponding period of 2022: Fourth quarter revenues were $15.1 million, an increase of 9%Fourth quarter net income was $4.2 million, an increase of 31%Full year revenues were $68.2 million, an increase of 20%Full year net income was $20.6 million, an increase of 44%Cash balance increased to $57.3 millionSANTA CLARA, Calif., March 5, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today reported financial results for the fourth quarter and full year ended December 31, 2023.
SANTA CLARA, Calif., Feb. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023, after the close of U.S. financial markets on Tuesday, March 5, 2024. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, chief financial officer, and Jennifer Oliva-Herrington, chief operating officer, will join him on the call.
2023 Q2 highlights: Revenue was $18.6 million, an increase of 25% compared to the corresponding period of 2022Net income was $5.9 million, an increase of 44% compared to the corresponding period of 2022Cash, cash equivalents and short-term investments of $51.8 millionSANTA CLARA, Calif., Aug. 10, 2023 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today reported financial results for the three and six months ended June 30, 2023.
Semler Scientific's (NYSE:SMLR) short percent of float has risen 123.04% since its last report. The company recently reported that it has 477 thousand shares sold short, which is 8.52% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.32 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short int
Gainers Seres Therapeutics (NASDAQ:MCRB) stock moved upwards by 34.0% to $0.82 during Monday's regular session. The company's market cap stands at $124.5 million. Renovaro (NASDAQ:RENB) shares increased by 32.51% to $1.71. The market value of their outstanding shares is at $252.1 million. Champions Oncology (NASDAQ:CSBR) shares increased by 22.82% to $5.65. The company's market cap stands at $76.8 million. Nanoviricides (AMEX:NNVC) stock rose 22.02% to $3.26. The market value of their outstanding shares is at $38.4 million. Semler Scientific (NASDAQ:SMLR) stock moved upwards by 20.13% to $38.0. The market value of their outstanding shares is at $268.5 million. TransCode Therapeutics (N
Healthcare company Semler Scientific Inc. (NASDAQ:SMLR) doubled down on its Bitcoin (CRYPTO: BTC) investments by purchasing an additional $17 million of the world's largest digital asset. What Happened: In a press release shared Thursday, the medical device manufacturer said it bought 247 Bitcoins for an aggregate value of $17 million. With the latest grab, the company's total Bitcoin holdings shot up to 828, worth more than $58 million at the prevailing price of the King Crypto. The company identified purchasing and holding Bitcoins as one of its two primary priorities, the other being expanding its healthcare operations, and said it will continue to buy more Bitcoins with cash.
As of June 6, 2024, Semler holds a total of 828 bitcoins, which were acquired for an aggregate $57 million, inclusive of fees and expenses.
Corporations are turning to Bitcoin to protect themselves from traditional financial risks and benefit from increases in Bitcoin's value. As a liquid asset outside the traditional financial system, Bitcoin allows companies to continue operations and meet short-term obligations, such as paying employees, in case of banking system disruptions. A Bitcoin allocation enables companies to benefit from its potential increase in value, as it has been the best-performing asset of the last decade, and global adoption continues to increase. Bitcoin's scarcity and secure, decentralized network make it an attractive store of value compared to less scarce assets traded on centralized networks. Impact of
Shares of Bank of Montreal (NYSE:BMO) fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter financial results. Bank of Montreal posted quarterly adjusted earnings of C$2.59 per share, missing market estimates of C$2.77 per share. The company's quarterly sales came in at C$7.988 billion missing expectations of C$8.046 billion, according to data from Benzinga Pro. Bank of Montreal shares declined 7.1% to $89.32 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers ReShape Lifesciences Inc. (NASDAQ:RSLS) shares jumped 82.8% to $0.3799 a day after it received the nod from the U.S. Patent And Trademark O
U.S. stocks were lower, with the Dow Jones index falling more than 300 points on Wednesday. Shares of HEICO Corporation (NYSE:HEI) rose sharply during Wednesday's session following a second-quarter earnings beat. Heico posted quarterly GAAP earnings of 88 cents per share, beating market estimates of 81 cents per share. The company's quarterly sales came in at $955.395 million versus expectations of $951.206 million, according to data from Benzinga Pro. HEICO shares gained 4.6% to $221.76 on Wednesday. Here are some other big stocks recording gains in today's session. AST SpaceMobile, Inc. (NASDAQ:ASTS) shares gained 29% to $6.88 after the company announced a partnership with
Gainers Sharps Technology (NASDAQ:STSS) stock rose 140.0% to $0.51 during Tuesday's regular session. The company's market cap stands at $8.0 million. Insmed (NASDAQ:INSM) stock moved upwards by 112.72% to $46.8. The company's market cap stands at $6.9 billion. Calliditas Therapeutics (NASDAQ:CALT) shares moved upwards by 69.26% to $37.95. The company's market cap stands at $1.0 billion. The company's, Q1 earnings came out 3 days ago. Predictive Oncology (NASDAQ:POAI) shares rose 36.54% to $2.14. The company's market cap stands at $8.7 million. Semler Scientific (NASDAQ:SMLR) stock moved upwards by 28.55% to $29.98. The company's market cap stands at $211.8 million. Exicure (NASDAQ:XCUR
Semler Scientific, Inc. (NASDAQ:SMLR) shares are trading higher on Tuesday after the company announced that its board of directors adopted bitcoin as its primary treasury reserve asset. In addition, Semler Scientific announced that it had purchased 581 bitcoins for an aggregate amount of $40 million, inclusive of fees and expenses. Bitcoin will serve as the primary treasury holding on an ongoing basis, pending market conditions and Semler Scientific’s anticipated cash requirements. “Bitcoin is now a major asset class with more than $1 trillion of market value. We believe it has unique characteristics as a scarce and finite asset that can serve as a reasonable inflation hedge and saf
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13G/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13G/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13G - Semler Scientific, Inc. (0001554859) (Subject)
SC 13G/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13G/A - Semler Scientific, Inc. (0001554859) (Subject)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4/A - Semler Scientific, Inc. (0001554859) (Issuer)
4/A - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)